These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8537889)

  • 1. Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparison.
    Veng-Pedersen P; Wilhelm JA; Zakszewski TB; Osifchin E; Waters SJ
    J Pharm Sci; 1995 Sep; 84(9):1101-6. PubMed ID: 8537889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
    Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of potency and duration of action of nalmefene and naloxone.
    Glass PS; Jhaveri RM; Smith LR
    Anesth Analg; 1994 Mar; 78(3):536-41. PubMed ID: 8109774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
    Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
    J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone.
    Freye E; Hartung E; Kaliebe S
    Br J Anaesth; 1983 Jan; 55(1):71-7. PubMed ID: 6129881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.
    Ellison M; Hutton E; Webster L; Skolnick P
    J Clin Pharmacol; 2024 Jul; 64(7):828-839. PubMed ID: 38436495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone reversal of opioid anesthesia revisited: clinical evaluation and plasma concentration analysis of continuous naloxone infusion after anesthesia with high-dose fentanyl.
    Takahashi M; Sugiyama K; Hori M; Chiba S; Kusaka K
    J Anesth; 2004; 18(1):1-8. PubMed ID: 14991468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged blockade of opioid effect with oral nalmefene.
    Gal TJ; DiFazio CA; Dixon R
    Clin Pharmacol Ther; 1986 Nov; 40(5):537-42. PubMed ID: 3533370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection.
    Papich MG; Narayan RJ
    Drug Deliv Transl Res; 2022 Feb; 12(2):376-383. PubMed ID: 34817831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged antagonism of opioid action with intravenous nalmefene in man.
    Gal TJ; DiFazio CA
    Anesthesiology; 1986 Feb; 64(2):175-80. PubMed ID: 3946804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of morphine-induced respiratory depression with nalmefene.
    Konieczko KM; Jones JG; Barrowcliffe MP; Jordan C; Altman DG
    Br J Anaesth; 1988 Sep; 61(3):318-23. PubMed ID: 3140862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose.
    Kaplan JL; Marx JA; Calabro JJ; Gin-Shaw SL; Spiller JD; Spivey WL; Gaddis GM; Zhao N; Harchelroad FP
    Ann Emerg Med; 1999 Jul; 34(1):42-50. PubMed ID: 10381993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
    Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
    Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of the opioid antagonist, nalmefene, in rat and dog.
    Murthy SS; Mathur C; Kvalo LT; Lessor RA; Wilhelm JA
    Xenobiotica; 1996 Jul; 26(7):779-92. PubMed ID: 8819305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex.
    Drugs R D; 1999 Jan; 1(1):32-3. PubMed ID: 10565979
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of oxymorphone sedation by naloxone, nalmefene, and butorphanol.
    Dyson DH; Doherty T; Anderson GI; McDonell WN
    Vet Surg; 1990; 19(5):398-403. PubMed ID: 2219678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats.
    Yong Z; Gao X; Ma W; Dong H; Gong Z; Su R
    Eur J Pharmacol; 2014 Sep; 738():153-7. PubMed ID: 24886878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.
    Ingman K; Hagelberg N; Aalto S; Någren K; Juhakoski A; Karhuvaara S; Kallio A; Oikonen V; Hietala J; Scheinin H
    Neuropsychopharmacology; 2005 Dec; 30(12):2245-53. PubMed ID: 15956985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.